Skip to content
DataLookout
Menu

SASOVNCT07933705

Surgery Versus Intra-lesional Sclerosis With Polidocanol (Aetoxisclerol) in Labial Venous Malformations in Children and Adults

StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Global change
Timeframe: From enrollment to Month 12 post intervention

Secondary (14)

Aesthetic impact of the venous malformation
Functional impact: overall mouth function
Functional impact: lip continence
Functional impact: speech intelligibility
Overall patient satisfaction: Likert scale
Show 9 moreShow less
Overall patient satisfaction: Goal Attainment Scale
Number of painful days: Total number of painful days
Number of painful days: Number of painful days with a VAS pain score > 3/10
Venous Malformation volume on MRI
Coagulation: D-dimer
Coagulation: fibrinogen level
Adverse events including complications
Acceptability of the interventions
Healthcare costs

Arms and interventions

Surgical strategyExperimental

Experimental group: Surgical strategy for the excision of the superficial venous malformation (SVM). The surgery involves either partial reconstructive excision or complete excision of the SVM, depending on its size. The aim is to restore symmetry to the affected side of the lip in order to correct functional impairments and aesthetic effects.

Sclerotherapy strategyActive comparator

Control group: Sclerotherapy strategy comprising one to two sessions of intra-lesional sclerotherapy with 3% polidocanol (Aetoxisclerol).

Procedures: Excision by surgery of the superficial venous malformation

Drugs: Sclerotherapy with Aetoxisclerol 3%

Sites

3 sites in 1 country